Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
DRONE Act of 2025
Client: HOLLAND & KNIGHT LLP (ON BEHALF OF THE CITY OF TAMPA) · Firm: MANATT, PHELPS, AND PHILLIPS
H.R. 9170 - Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027; Community Project Funding/Congressional Directed Spending; H.R. 1058 - Directing Resources for Officers Navigating Emergencies (DRONE ACT of 2025); Palmetto Mobility Improvements Build agreement;
Issues related to drugs of abuse testing; RESULTS Act (H.R.5269/S. 2761)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2026 · third_quarter · Q3
Representation on issues related to patient access and Medicare. Advancing innovation in clinical trials and cancer therapies.
Representation on issues related to patient access and Medicare. Advancing innovation in clinical trials and cancer therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| DATASPRING (FKA COUNCIL FOR AFFORDABLE QUALITY HEALTHCARE) |
| 4 |
| 2026 |
| GUARDANT HEALTH | 4 | 2024–2025 |
| HEALTH ACCESS CA | 4 | 2025 |
| LOMA LINDA UNIVERSITY MEDICAL CENTER | 4 | 2025–2026 |
| PROVIDER RESOURCES LLC | 2 | 2026 |
| CITY OF DES MOINES, IOWA | 1 | 2026 |
| HOLLAND & KNIGHT LLP (ON BEHALF OF THE CITY OF TAMPA) | 1 | 2026 |
| MAINSTAY MEDICAL | 1 | 2024 |
Issues related to drugs of abuse testing; RESULTS Act (H.R.5269/S. 2761)
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027
Client: HOLLAND & KNIGHT LLP (ON BEHALF OF THE CITY OF TAMPA) · Firm: MANATT, PHELPS, AND PHILLIPS
H.R. 9170 - Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027; Community Project Funding/Congressional Directed Spending; H.R. 1058 - Directing Resources for Officers Navigating Emergencies (DRONE ACT of 2025); Palmetto Mobility Improvements Build agreement;
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027
Client: CITY OF DES MOINES, IOWA · Firm: MANATT, PHELPS, AND PHILLIPS
H.R. 9170- Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027.
Issues related to drugs of abuse testing; RESULTS Act (H.R.5269/S. 2761)
Issues related to drugs of abuse testing; RESULTS Act (H.R.5269/S. 2761)
2026 · third_quarter · Q3
Issues regarding the No Surprises Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOLLAND & KNIGHT LLP (ON BEHALF OF THE CITY OF TAMPA) via MANATT, PHELPS, AND PHILLIPS
2026 · third_quarter · Q3
H.R. 9170 - Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027; Community Project Funding/Congressional Directed Spending; H.R. 1058 - Directing Resources for Officers Navigating Emergencies (DRONE ACT of 2025); Palmetto Mobility Improvements Build agreement;
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
CITY OF DES MOINES, IOWA via MANATT, PHELPS, AND PHILLIPS
2026 · third_quarter · Q3
H.R. 9170- Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
SENSEONICS, INC. via MANATT, PHELPS, AND PHILLIPS
2026 · third_quarter · Q3
Issues related to device reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MILLENNIUM HEALTH via MANATT, PHELPS, AND PHILLIPS
2026 · third_quarter · Q3
Issues related to drugs of abuse testing; RESULTS Act (H.R.5269/S. 2761)
Issues related to drugs of abuse testing; RESULTS Act (H.R.5269/S. 2761)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
LOMA LINDA UNIVERSITY MEDICAL CENTER via MANATT, PHELPS, AND PHILLIPS
2026 · third_quarter · Q3
Healthcare, Legislation Impacting Hospitals, Federal Funding/CPF and CDF
Healthcare, Legislation Impacting Hospitals, Federal Funding/CPF and CDF
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARLSMED INC via MANATT, PHELPS, AND PHILLIPS
2026 · third_quarter · Q3
Issues related to Medical Device Reimbursement
Issues related to Medical Device Reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DATASPRING via MANATT, PHELPS, AND PHILLIPS
2026 · third_quarter · Q3
Provider directory and provider credentialing issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PROVIDER RESOURCES LLC via MANATT, PHELPS, AND PHILLIPS
2026 · third_quarter · RR
Issues regarding the No Surprises Act
DENALI THERAPEUTICS via MANATT, PHELPS, AND PHILLIPS
2026 · third_quarter · Q3
Issues related to the Rare Pediatric Disease Priority Review Voucher (PRV) Program; Rare disease drug development
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MILLENNIUM HEALTH via MANATT, PHELPS, AND PHILLIPS
2026 · second_quarter · Q2
Issues related to drugs of abuse testing reimbursement
Issues related to drugs of abuse testing reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
DATASPRING via MANATT, PHELPS, AND PHILLIPS
2026 · second_quarter · Q2
Provider directory and provider credentialing issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
LOMA LINDA UNIVERSITY MEDICAL CENTER via MANATT, PHELPS, AND PHILLIPS
2026 · second_quarter · Q2
Healthcare, Legislation Impacting Hospitals, Federal Funding/CPF and CDF
Healthcare, Legislation Impacting Hospitals, Federal Funding/CPF and CDF
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2026 · second_quarter · Q2
Representation on issues related to patient access and Medicare. Advancing innovation in clinical trials and cancer therapies.
Representation on issues related to patient access and Medicare. Advancing innovation in clinical trials and cancer therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARLSMED INC via MANATT, PHELPS, AND PHILLIPS
2026 · second_quarter · Q2
Issues related to Medical Device Reimbursement
Issues related to Medical Device Reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DATASPRING via MANATT, PHELPS, AND PHILLIPS
2026 · first_quarter · Q1
Provider directory and provider credentialing issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MILLENNIUM HEALTH via MANATT, PHELPS, AND PHILLIPS
2026 · first_quarter · Q1
Issues related to drugs of abuse testing reimbursement
Issues related to drugs of abuse testing reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
STRYKER CORPORATION (FKA INARI MEDICAL) via MANATT, PHELPS, AND PHILLIPS
2026 · first_quarter · Q1
Funding for blood clot education and awareness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2026 · first_quarter · Q1
Representation on issues related to patient access and Medicare. Advancing innovation in clinical trials and cancer therapies.
Representation on issues related to patient access and Medicare. Advancing innovation in clinical trials and cancer therapies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CARLSMED INC via MANATT, PHELPS, AND PHILLIPS
2026 · first_quarter · Q1
Issues related to Medical Device Reimbursement
Issues related to Medical Device Reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LOMA LINDA UNIVERSITY MEDICAL CENTER via MANATT, PHELPS, AND PHILLIPS
2026 · first_quarter · Q1
Healthcare, Legislation Impacting Hospitals, Federal Funding/CPF and CDF
Healthcare, Legislation Impacting Hospitals, Federal Funding/CPF and CDF
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DATASPRING via MANATT, PHELPS, AND PHILLIPS
2026 · first_quarter · RR
National Provider Directory and provider credentialing issues
DENALI THERAPEUTICS via MANATT, PHELPS, AND PHILLIPS
2026 · first_quarter · Q1
Rare Pediatric Disease Priority Review Voucher (PRV) Program Reauthorization; Rare disease drug development
CARLSMED INC via MANATT, PHELPS, AND PHILLIPS
2025 · fourth_quarter · Q4
Issues related to Medical Device Reimbursement
Issues related to Medical Device Reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2025 · fourth_quarter · Q4
Representation on issues related to patient access and Medicare. Advancing innovation in clinical trials and cancer therapies.
Representation on issues related to patient access and Medicare. Advancing innovation in clinical trials and cancer therapies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
LOMA LINDA UNIVERSITY MEDICAL CENTER via MANATT, PHELPS, AND PHILLIPS
2025 · fourth_quarter · Q4
Healthcare, Legislation Impacting Hospitals, Federal Funding/CPF and CDF
Healthcare, Legislation Impacting Hospitals, Federal Funding/CPF and CDF
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MILLENNIUM HEALTH via MANATT, PHELPS, AND PHILLIPS
2025 · fourth_quarter · Q4
Issues related to drugs of abuse testing reimbursement
Issues related to drugs of abuse testing reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
DENALI THERAPEUTICS via MANATT, PHELPS, AND PHILLIPS
2025 · fourth_quarter · Q4
Rare Pediatric Disease Priority Review Voucher (PRV) Program Reauthorization; Rare disease drug development
SENSEONICS, INC. via MANATT, PHELPS, AND PHILLIPS
2025 · third_quarter · Q3
Medicare payment issue for physicians and hospital outpatient departments, Centers for Medicare & Medicaid Services.
MILLENNIUM HEALTH via MANATT, PHELPS, AND PHILLIPS
2025 · third_quarter · Q3
Issues related to drugs of abuse testing reimbursement, SAMHSA and HHS.
Issues related to drugs of abuse testing reimbursement, SAMHSA and HHS.
STRYKER CORPORATION (FKA INARI MEDICAL) via MANATT, PHELPS, AND PHILLIPS
2025 · third_quarter · Q3
Appropriations
Appropriations
DENALI THERAPEUTICS via MANATT, PHELPS, AND PHILLIPS
2025 · third_quarter · Q3
Rare Pediatric Disease Priority Review Voucher (PRV) Program Reauthorization; Rare disease drug development
SENSEONICS, INC. via MANATT, PHELPS, AND PHILLIPS
2025 · second_quarter · Q2
Medicare payment issue for physicians and hospital outpatient departments
MILLENNIUM HEALTH via MANATT, PHELPS, AND PHILLIPS
2025 · second_quarter · Q2
Issues related to drugs of abuse testing reimbursement.
Issues related to drugs of abuse testing reimbursement.
STRYKER CORPORATION (FKA INARI MEDICAL) via MANATT, PHELPS, AND PHILLIPS
2025 · second_quarter · Q2
Appropriations
Appropriations
GUARDANT HEALTH via MANATT, PHELPS, AND PHILLIPS
2025 · second_quarter · 2T
Appropriations and Healthcare
Appropriations and Healthcare
HEALTH ACCESS CA via MANATT, PHELPS, AND PHILLIPS
2025 · second_quarter · 2@
Impact of Medicaid cuts being considered under reconciliation.
HEALTH ACCESS CA via MANATT, PHELPS, AND PHILLIPS
2025 · second_quarter · 2T
Impact of Medicaid cuts being considered under reconciliation.
DENALI THERAPEUTICS via MANATT, PHELPS, AND PHILLIPS
2025 · second_quarter · Q2
Rare Pediatric Disease Priority Review Voucher (PRV) Program Reauthorization; Medicaid policies that impact access to innovative treatments for pediatric rare diseases; rare disease drug development
GUARDANT HEALTH via MANATT, PHELPS, AND PHILLIPS
2025 · first_quarter · Q1
Appropriations and Healthcare
Appropriations and Healthcare
SENSEONICS, INC. via MANATT, PHELPS, AND PHILLIPS
2025 · first_quarter · Q1
Medicare payment issue for physicians and hospital outpatient departments
MILLENNIUM HEALTH via MANATT, PHELPS, AND PHILLIPS
2025 · first_quarter · Q1
Issues related to drugs of abuse testing reimbursement.
Issues related to drugs of abuse testing reimbursement.
STRYKER CORPORATION (FKA INARI MEDICAL) via MANATT, PHELPS, AND PHILLIPS
2025 · first_quarter · Q1
Appropriations
Appropriations
DENALI THERAPEUTICS via MANATT, PHELPS, AND PHILLIPS
2025 · first_quarter · 1A
Rare Pediatric Disease Priority Review Voucher (PRV) Program Reauthorization; Medicaid policies that impact access to innovative treatments for pediatric rare diseases; rare disease drug development
DENALI THERAPEUTICS via MANATT, PHELPS, AND PHILLIPS
2025 · first_quarter · Q1
Rare Pediatric Disease Priority Review Voucher (PRV) Program Reauthorization; Medicaid policies that impact access to innovative treatments for pediatric rare diseases; rare disease drug development
DENALI THERAPEUTICS via MANATT, PHELPS, AND PHILLIPS
2025 · first_quarter · RR
Rare Pediatric Disease Priority Review Voucher (PRV) Program Reauthorization; Medicaid policies that impact access to innovative treatments for pediatric rare diseases; rare disease drug development
HEALTH ACCESS CA via MANATT, PHELPS, AND PHILLIPS
2025 · first_quarter · Q1
Impact of Medicaid cuts being considered under reconciliation.
HEALTH ACCESS CA via MANATT, PHELPS, AND PHILLIPS
2025 · first_quarter · RR
Impact of Medicaid cuts being considered under reconciliation.
GUARDANT HEALTH via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · Q4
Appropriations and Healthcare.
Appropriations and Healthcare.
SENSEONICS, INC. via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · Q4
Medicare payment issue for physicians and hospital outpatient departments.
MILLENNIUM HEALTH via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · Q4
Issues related to Drugs of Abuse Testing Reimbursement.
Issues related to Drugs of Abuse Testing Reimbursement.
INARI MEDICAL via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · Q4
Appropriations
Appropriations
INARI MEDICAL via MANATT, PHELPS, AND PHILLIPS
2024 · third_quarter · 3A
Appropriations
Appropriations
SENSEONICS, INC. via MANATT, PHELPS, AND PHILLIPS
2024 · third_quarter · 3A
Medicare payment issue for physicians and hospital outpatient departments.
SENSEONICS, INC. via MANATT, PHELPS, AND PHILLIPS
2024 · third_quarter · Q3
Medicare payment issue for physicians and hospital outpatient departments.
SENSEONICS, INC. via MANATT, PHELPS, AND PHILLIPS
2024 · third_quarter · RA
Medicare payment issue for physicians and hospital outpatient departments.
GUARDANT HEALTH via MANATT, PHELPS, AND PHILLIPS
2024 · third_quarter · Q3
Appropriations and Healthcare.
Appropriations and Healthcare.
INARI MEDICAL via MANATT, PHELPS, AND PHILLIPS
2024 · third_quarter · Q3
Appropriations
Appropriations
SENSEONICS, INC. via MANATT, PHELPS, AND PHILLIPS
2024 · third_quarter · RR
Medicare payment issue for physicians and hospital outpatient departments.
MAINSTAY MEDICAL via MANATT, PHELPS, AND PHILLIPS
2024 · third_quarter · Q3
Issues related to medical device reimbursement
Issues related to medical device reimbursement.